Clinical Trial

Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This long-term follow-up study is being conducted to collect long-term (up to 15 years post-infusion) safety and tolerability data from subjects enrolled in studies evaluating TX200-TR101.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-08-03; most recent amendment 2025-12-03.
Status change: Enrolling by Invitation → Active, Not Recruiting 2025-12-03
Trial Details
NCT Number NCT05987527
Lead Sponsor Sangamo Therapeutics
Conditions Kidney Transplant Rejection, End Stage Renal Disease
Enrollment 11 participants
Start Date 2023-08-15
Primary Completion 2039-06-11 (estimated)
Study Completion 2039-06-11 (estimated)
Updated on ClinicalTrials.gov 2025-12-04